C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
167/130, 195/1.2
C12N 7/01 (2006.01) A61K 39/245 (2006.01) A61K 39/275 (2006.01) A61K 39/295 (2006.01) C07K 14/03 (2006.01) C07K 14/035 (2006.01) C07K 14/045 (2006.01) C07K 14/05 (2006.01) C12N 15/863 (2006.01) A61K 38/00 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2014465
What is described is a recombinant poxvirus, such as vaccinia virus, fowlpox virus and canarypox virus, containing foreign DNA from herpesvirus. In one embodiment, the foreign DNA is expressed in a host by the production of a herpesvirus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two, particularly two or three, herpesvirus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, the barrier of maternal immunity in a newborn offspring can be overcome or avoided.
Health Research Incorporated
Smart & Biggar
LandOfFree
Herpesvirus recombinant poxvirus vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Herpesvirus recombinant poxvirus vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Herpesvirus recombinant poxvirus vaccine will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1645411